Interleukin-8, a promising predictor for prognosis of pancreatic cancer
Interleukin-8, a promising predictor for prognosis of pancreatic cancer
复制标题
Interleukin-8,一种有前景的胰腺癌预后预测因子。
DOI:
10.3748/wjg.v18.i10.1123
复制
发表时间:
2012-03-14
影响因子:
4.3
通讯作者:
Zhu, Ming-Hua
中科院分区:
文献类型:
--
作者:
Chen, Ying;Shi, Min;Zhu, Ming-Hua
AIM: To investigate the value of interleukin-8 (IL-8), a pro-inflammatory chemokine, in predicting the prognosis of pancreatic cancer.METHODS: Expression of IL-8 and its receptor CXCR1 was assessed by immunohistochemistry in pancreatic cancer and chronic pancreatitis samples. Enzyme-linked immunosorbent assay was used to detect the serum IL-8 levels in pancreatic cancer patients. Human pancreatic cancer tissues were heterotopically transplanted to the immune-deficiency mice to evaluate the effect of serum IL-8 on the tumorigenesis of the cancer samples.RESULTS: IL-8 and CXCR1 proteins were both overexpressed in pancreatic adenocarcinoma samples (55.6% and 65.4%, respectively) compared with the matched para-cancer tissues (25.9% and 12.3%, P < 0.01), or chronic pancreatitis (0% and 25%, P < 0.05). Serum IL-8 levels in pancreatic cancer patients (271.1 +/- 187.7 ng/mL) were higher than in other digestive system tumors, such as gastric cancer (41.77 +/- 9.11 ng/mL, P = 0.025), colorectal carcinoma (78.72 +/- 80.60 ng/mL, P = 0.032) and hepatocellular carcinoma (59.60 +/- 19.80 ng/mL, P = 0.016). In vivo tumorigenesis analysis further proved that tumor tissues from patients with higher serum IL-8 levels grew faster than those with lower IL-8 levels.CONCLUSION: IL-8 can be a fine serum marker for predicting the prognosis pancreatic cancer. (c) 2012 Baishideng. All rights reserved.